Japan Nuclear Medicine Radioisotopes Market Size & Forecast 2025 - 2035: Growing Demand in Oncology and Diagnostics | GE Healthcare, Bayer, Cardinal Health

Tokyo, Japan, DataM Intelligence: The Japan Nuclear Medicine Radioisotopes Market is valued at approximately USD 641.7 million in 2024 and is projected to reach USD 1.899 billion by 2035, growing at a CAGR of 10.37% during the forecast period of 2025 to 2035.

This growth is driven by rising prevalence of cancer and cardiovascular diseases, advancements in nuclear medicine technologies, increasing aging population, and strong government support for research and development in nuclear medicine.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/nuclear-medicine-radioisotopes-market?ram

Japan: Key Industry Developments

✅ August 2025: GE Healthcare launched a new generation of high-sensitivity PET radioisotopes and tracers designed for early cancer detection and precision imaging.

✅ July 2025: Cardinal Health expanded its distribution network and production capacity for technetium-99m generators, ensuring stable supply in Japan's healthcare sector.

✅ June 2025: Lantheus Medical Imaging introduced cutting-edge theranostic radioisotopes combining diagnostic and therapeutic capabilities, enhancing personalized treatment approaches.

Mergers and Acquisitions (2025) - Nuclear Medicine Radioisotopes Market:

✅ GE Healthcare acquired a Japanese biotech startup specializing in novel radioisotope production to accelerate development of advanced nuclear medicine agents.

✅ Cardinal Health partnered with a major Japanese pharmaceutical company to co-develop next-generation diagnostic radioisotopes with improved efficacy and safety profiles.

✅ Lantheus Medical Imaging formed a strategic alliance with a research institution in Japan to expand clinical trials for innovative theranostic radioisotopes.

Key Players:

-NTP Radioisotopes SOC Ltd - Specializes in producing and supplying medical radioisotopes globally for diagnostic and therapeutic use.

-Nordion Inc. (Sotera Health Company) - Provides gamma technologies and medical isotopes for healthcare and sterilization industries.

-Cardinal Health, Inc. - Distributes nuclear medicine products and radiopharmaceuticals for healthcare providers.

-Bayer AG - Develops radiopharmaceuticals and diagnostic imaging agents for oncology and cardiovascular applications.

-GE Company (GE Healthcare) - Offers advanced medical imaging and molecular diagnostics using radioisotopes.

-NorthStar Medical Radioisotopes, LLC - Focuses on producing and supplying non-uranium-based radioisotopes for medical imaging.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=nuclear-medicine-radioisotopes-market?ram (Purchase 2 or more Reports and get 50% Discount)

Key Segments:

➥ By Type of Radioisotopes: Fluorine-18, Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Rubidium-82 (Rb-82), Iodine-131 (I-131), Lutetium-177 (Lu-177), Radium-223 (Ra-223) and Alpharadin, Actinium-225 (Ac-225), Other Types of Radioisotopes
➥ By Application: Cardiology, Oncology, Thyroid, Neurology, Other Applications
➥ By End-User: Hospitals, Diagnostic Centers, Specialty Clinics, Education and Research Institutes, Others

Latest Industry Trends and News:

-Expansion of theranostic applications, combining diagnosis and therapy in personalized medicine.

-Increasing production capabilities for key radioisotopes like technetium-99m to alleviate supply constraints.

-Rising collaborations between pharmaceutical companies and academic research centers driving innovation.

-Japan emerging as a hub for nuclear medicine innovation and clinical research in the Asia-Pacific region.

Market Dynamics and Growth Drivers:

-Increasing prevalence of chronic diseases like cancer and cardiovascular disorders increasing demand for nuclear diagnostic and therapeutic procedures.

-Technological advancements in PET, SPECT imaging, and theranostics enhance diagnostic accuracy and treatment efficacy.

-Growing geriatric population raising demand for advanced medical imaging solutions for early disease detection.

-Government initiatives supporting nuclear medicine infrastructure development and regulatory facilitation.

Research Process:

Both primary and secondary data sources have been used in the Global Nuclear Medicine Radioisotopes Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Speak to Our Analyst and get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/nuclear-medicine-radioisotopes-market?ram

Q1: What is the current size of the Nuclear Medicine Radioisotopes Market?

A: In 2024, the Nuclear Medicine Radioisotopes Market was valued at USD 641.7 million, reflecting its strong industry presence.

Q2: How large is the Nuclear Medicine Radioisotopes Market expected to be by 2035?

A: By 2035, industry forecasts suggest the Nuclear Medicine Radioisotopes Market will grow to around USD 1.899 billion, demonstrating significant expansion.

Q3: What is the growth rate of the Nuclear Medicine Radioisotopes Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 10.37% during the forecast period from 2025 to 2035.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.